# Rollover Protocol for Prior SU011248 Protocols

> **NCT00798889** · NA · COMPLETED · sponsor: **Pfizer** · enrollment: 314 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** Sunitinib

## Key facts

- **NCT ID:** NCT00798889
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 314 (ACTUAL)
- **Last updated:** 2013-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00798889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00798889, "Rollover Protocol for Prior SU011248 Protocols". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00798889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*